
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
USP51/PD‐L1/ITGB1‐deployed juxtacrine interaction plays a cell‐intrinsic role in promoting chemoresistant phenotypes in non‐small cell lung cancer
Jianjun Li, Xuechun Xiao, Yang Ou, et al.
Cancer Communications (2023) Vol. 43, Iss. 7, pp. 765-787
Open Access | Times Cited: 22
Jianjun Li, Xuechun Xiao, Yang Ou, et al.
Cancer Communications (2023) Vol. 43, Iss. 7, pp. 765-787
Open Access | Times Cited: 22
Showing 22 citing articles:
Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application
Hongli Gao, Jianqiao Yin, Ce Ji, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 51
Hongli Gao, Jianqiao Yin, Ce Ji, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 51
Recent Advances in Small Molecule Inhibitors of Deubiquitinating Enzymes
Pengwei Liu, Zhengyang Chen, Yiting Guo, et al.
European Journal of Medicinal Chemistry (2025), pp. 117324-117324
Closed Access | Times Cited: 4
Pengwei Liu, Zhengyang Chen, Yiting Guo, et al.
European Journal of Medicinal Chemistry (2025), pp. 117324-117324
Closed Access | Times Cited: 4
Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways
Rong Wang, Shiwei He, Jun Long, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Rong Wang, Shiwei He, Jun Long, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 10
PD-L1 induces autophagy and primary resistance to EGFR–TKIs in EGFR-mutant lung adenocarcinoma via the MAPK signaling pathway
Na Li, Ran Zuo, Yuchao He, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 10
Na Li, Ran Zuo, Yuchao He, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 10
CircRNF13 enhances IGF2BP1 phase separation-mediated ITGB1 mRNA stabilization in an m6A-dependent manner to promote oral cancer cisplatin chemoresistance
Xuemeng Xu, Peng Qiu, Zongyao Ren, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Xuemeng Xu, Peng Qiu, Zongyao Ren, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Cinobufotalin regulates the USP36/c-Myc axis to suppress malignant phenotypes of colon cancer cells in vitro and in vivo
Yongjun Hu, Ming Luo
Aging (2024) Vol. 16, Iss. 6, pp. 5526-5544
Open Access | Times Cited: 5
Yongjun Hu, Ming Luo
Aging (2024) Vol. 16, Iss. 6, pp. 5526-5544
Open Access | Times Cited: 5
Berbamine promotes ferroptosis of esophageal squamous cell carcinoma by facilitating USP51-mediated GPX4 ubiquitination and degradation
Hao Peng, YuanPeng He, Yuepeng Hu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117309-117309
Open Access | Times Cited: 4
Hao Peng, YuanPeng He, Yuepeng Hu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117309-117309
Open Access | Times Cited: 4
Regulating Itgb1 to Restore GnRH-Tanycyte Unit Function in PCOS-Related Hypothalamic Dysregulation
Yu Wang, Xiaoyu Tong, Yan Xiao, et al.
Research (2025) Vol. 8
Open Access
Yu Wang, Xiaoyu Tong, Yan Xiao, et al.
Research (2025) Vol. 8
Open Access
The Hidden Potential of Solasonine: Targeting Non-Small Cell Lung Cancer (NSCLC) Metastasis Through GATM and Smad2 Pathways
Cheng Hu, Jiaqi Zhang, Xiaoyu Zhuang, et al.
Phytomedicine (2025) Vol. 139, pp. 156455-156455
Closed Access
Cheng Hu, Jiaqi Zhang, Xiaoyu Zhuang, et al.
Phytomedicine (2025) Vol. 139, pp. 156455-156455
Closed Access
NAD+ Metabolism Reprogramming Drives SIRT1‐Dependent Deacetylation Inducing PD‐L1 Nuclear Localization in Cervical Cancer
Xinyi Lu, Pingping Jin, Qianyun Tang, et al.
Advanced Science (2025)
Open Access
Xinyi Lu, Pingping Jin, Qianyun Tang, et al.
Advanced Science (2025)
Open Access
Flavonoids in the Treatment of Non-small Cell Lung Cancer via Immunomodulation: Progress to Date
Mengdi Liang, Yang Huang, Shengfeng Huang, et al.
Molecular Diagnosis & Therapy (2025)
Closed Access
Mengdi Liang, Yang Huang, Shengfeng Huang, et al.
Molecular Diagnosis & Therapy (2025)
Closed Access
USP51/GRP78/ABCB1 axis confers chemoresistance through decreasing doxorubicin accumulation in triple-negative breast cancer cells
Yang Ou, Kun Zhang, Qiuying Shuai, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Yang Ou, Kun Zhang, Qiuying Shuai, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Emerging role of deubiquitinases in modulating cancer chemoresistance
Sukeerthi Dasharathy, Pranay, Santhosh K Devdas, et al.
Drug Discovery Today (2025), pp. 104339-104339
Closed Access
Sukeerthi Dasharathy, Pranay, Santhosh K Devdas, et al.
Drug Discovery Today (2025), pp. 104339-104339
Closed Access
Integrins in Cancer Drug Resistance: Molecular Mechanisms and Clinical Implications
Yoshinobu Kariya, Michiru Nishita
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3143-3143
Open Access
Yoshinobu Kariya, Michiru Nishita
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3143-3143
Open Access
Mechanistic Insights and Therapeutic Potentials of Ubiquitin‐Proteasome System in Non‐Small Cell Lung Cancer
Guangyao Zhou, Jiaxiong Tan, Zhenfa Zhang, et al.
Cell Proliferation (2025)
Open Access
Guangyao Zhou, Jiaxiong Tan, Zhenfa Zhang, et al.
Cell Proliferation (2025)
Open Access
Ubiquitin-conjugating enzyme UBE2N modulates proteostasis in immunoproteasome-positive acute myeloid leukemia
Chiharu Ishikawa, Laura Barreyro, Avery Sampson, et al.
Journal of Clinical Investigation (2025) Vol. 135, Iss. 10
Open Access
Chiharu Ishikawa, Laura Barreyro, Avery Sampson, et al.
Journal of Clinical Investigation (2025) Vol. 135, Iss. 10
Open Access
Exploration of a screening model for intrahepatic cholangiocarcinoma patients prone to cuproptosis and mechanisms of the susceptibility of CD274-knockdown intrahepatic cholangiocarcinoma cells to cuproptosis
Zefeng Shen, Jingwei Cai, Liye Tao, et al.
Cancer Gene Therapy (2023) Vol. 30, Iss. 12, pp. 1663-1678
Closed Access | Times Cited: 5
Zefeng Shen, Jingwei Cai, Liye Tao, et al.
Cancer Gene Therapy (2023) Vol. 30, Iss. 12, pp. 1663-1678
Closed Access | Times Cited: 5
Postoperative radiotherapy with docetaxel versus cisplatin for high-risk oral squamous cell carcinoma: a randomized phase II trial with exploratory analysis of ITGB1 as a potential predictive biomarker
Wen Jiang, Lan Chen, Rongrong Li, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Wen Jiang, Lan Chen, Rongrong Li, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
The prognostic value of bioinformatics analysis of ECM receptor signaling pathways and LAMB1 identification as a promising prognostic biomarker of lung adenocarcinoma
Tingjun Liu, jing Liu, Quangang Chen, et al.
Medicine (2024) Vol. 103, Iss. 38, pp. e39854-e39854
Open Access
Tingjun Liu, jing Liu, Quangang Chen, et al.
Medicine (2024) Vol. 103, Iss. 38, pp. e39854-e39854
Open Access
Assessing the metastatic potential of circulating tumor cells using an organ-on-chip model
Karin Farah Schmid, Soheila Zeinali, Susanne Karoline Moser, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access
Karin Farah Schmid, Soheila Zeinali, Susanne Karoline Moser, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access
USP5 Stabilizes IKBKG Through Deubiquitination to Suppress Ferroptosis and Promote Growth in Non-small Cell Lung Cancer
Yufu Li, Gan Qiu, Min Zhou, et al.
Cell Biochemistry and Biophysics (2024)
Closed Access
Yufu Li, Gan Qiu, Min Zhou, et al.
Cell Biochemistry and Biophysics (2024)
Closed Access
Postoperative Radiotherapy with Docetaxel Versus Cisplatin for High-Risk Oral Squamous Cell Carcinoma: A Randomized Phase II Trial with Exploratory Analysis of ITGB1 as a Potential Predictive Biomarker
Wen Jiang, Yanli Yao, Rongrong Li, et al.
(2023)
Closed Access
Wen Jiang, Yanli Yao, Rongrong Li, et al.
(2023)
Closed Access